Significant comorbidities discovered in participants with NT-proBNP ≥900 on clinical examination
| Number | Comorbidity | NT-proBNP (ng/L) | Measure |
| 1 | Severe aortic stenosis | 1015 | Aortic valve replacement |
| 2 | Severe aortic stenosis | 1200 | Aortic valve replacement |
| 3 | Moderate aortic stenosis | 2500 | Follow-up |
| 4 | Severe aortic regurgitation | 940 | Aortic valve replacement |
| 5 | Moderate aortic regurgitation | 3936 | Follow-up |
| 6 | Sick sinus syndrome | 1010 | Pacemaker |
| 7 | Sick sinus syndrome | 2133 | Pacemaker |
| 8 | Hypertrophic obstructive cardiomyopathy | 1200 | Follow-up |
| 9 | Severe chronic renal failure* | 3258 | Dialysis |
| 10 | Amyloidosis | 1400 | Follow-up |
| 11 | Amyloidosis | 912 | Follow-up |
| 12 | Amyloidosis | 1917 | Follow-up |
| 13 | Angina pectoris with significant ischaemic coronary heart disease | 1000 | PCI of significant LAD stenosis |
*Glomerular filtration rate <10 mL/min.
LAD, left anterior descending coronary artery; NT-proBNP, N-terminal pro-B-type natriuretic peptide; PCI, percutaneous coronary intervention.